RecruitingNCT07496242
Immunological Phenotype of Desmoid-fibromatosis-affected Patients.
Studying Desmoid tumor
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
- Principal Investigator
- Chiara Colombo, MD, Surgical OncologistFondazione IRCCS Istituto Nazionale dei Tumori di Milano
- Enrollment
- 200 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2025 – 2026
Study locations (8)
- IRCCS Istituto di Candiolo Fondazione del Piemonte per l'Oncologia, Candiolo, Italy
- Azienda Ospedaliero Universitaria Careggi, Florence, Italy
- Azienda Usl Toscana centro, Florence, Italy
- Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
- IRCCS Istituto Oncologico Veneto IOV, Padua, Italy
- Azienda Ospedaliera Universitaria Policlinico "Paolo Giaccone", Palermo, Italy
- Università Campus Bio-Medico, Rome, Italy
- Erasmus University Medical Centre, Rotterdam, Netherlands
Collaborators
Campus Biomedico - Roma · Candiolo Cancer Institute - IRCCS · Azienda Ospedaliero-Universitaria Careggi · Azienda USL Toscana Centro · Azienda Ospedaliera Universitaria Policlinico Paolo Giaccone Palermo · Erasmus University Rotterdam · Istituto Oncologico Veneto IRCCS
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT07496242 on ClinicalTrials.govOther trials for Desmoid tumor
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT07541430A Study in Adults With Desmoid TumorsElpiscience (Suzhou) Biopharma, Ltd.
- RECRUITINGPHASE4NCT07176689Nirogacestat in Premenopausal Females With Desmoid Tumor/Aggressive Fibromatosis (DT/AF)SpringWorks Therapeutics, Inc.
- ACTIVE NOT RECRUITINGPHASE2NCT07170644A Study of Nirogacestat in Japanese Adults With Desmoid Tumors/Aggressive Fibromatosis (DT/AF)SpringWorks Therapeutics, Inc.
- RECRUITINGNCT06945887Treatment of Desmoid Fibromatosis With Arterial EmbolizationIstituto Ortopedico Rizzoli
- RECRUITINGPHASE2NCT05879146Evaluation of the Response and Non-response of Nirogacestat in Desmoid Tumors- Clinical StudyM.D. Anderson Cancer Center
- RECRUITINGNCT06660121Electrochemotherapy for Desmoid TumorsIstituto Ortopedico Rizzoli
- RECRUITINGNANCT06081400Cryoablation Versus Medical Therapy in Desmoid Tumors Progressing After Watchful WaitingUniversity Hospital, Strasbourg, France
- RECRUITINGNCT06224283Radiomics Compared With Conventional Response Criteria for Predicting Progression of Desmoid Tumor After CryoablationIstituto Ortopedico Rizzoli